Oncology Institute (NASDAQ:TOIIW) & Chemed (NYSE:CHE) Financial Analysis

Oncology Institute (NASDAQ:TOIIW) and Chemed (NYSE:CHE) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Profitability

This table compares Oncology Institute and Chemed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Oncology Institute	N/A	N/A	N/A
Chemed	10.36%	34.65%	20.25%

Institutional and Insider Ownership

94.3% of Chemed shares are held by institutional investors. 4.0% of Chemed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of current recommendations and price targets for Oncology Institute and Chemed, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oncology Institute	0	0	0	0	N/A
Chemed	0	0	1	0	3.00

Chemed has a consensus target price of $593.00, suggesting a potential upside of 15.76%. Given Chemed’s higher possible upside, analysts clearly believe Chemed is more favorable than Oncology Institute.

Valuation and Earnings

This table compares Oncology Institute and Chemed’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oncology Institute	$292.82 million	N/A	N/A	N/A	N/A
Chemed	$2.19 billion	3.53	$249.62 million	$15.00	34.15

Chemed has higher revenue and earnings than Oncology Institute.

Summary

Chemed beats Oncology Institute on 8 of the 8 factors compared between the two stocks.

About Oncology Institute

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients. The company was founded in 2007 and is based in Cerritos, California.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.